A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 150
- 试验地点
- 40
- 主要终点
- Description of the clinical, histological and radiological characteristics of various rare primary liver cancers
研究概览
简要总结
The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational studies aimed at identifying new molecular, histological, circulating and radiological tumor biomarkers, potentially useful at every stage of diagnosis and prognostic or theranostic evaluation.
详细描述
The aim is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older,
- •with histologically proven hepato-cholangiocarcinoma, fibrolamellar hepatocellular carcinoma, epithelioid hemangioendothelioma or hepatic angiosarcoma
- •diagnosed after January 01, 2018 living or deceased at the time of registration in the cohort
- •for living patients who have not objected to the research: (note of non-objection to be attached° agreeing to participate in ancillary studies must sign the biological consent form for participation in biological studies.
排除标准
- •without social security
- •No access to tumor block
结局指标
主要结局
Description of the clinical, histological and radiological characteristics of various rare primary liver cancers
时间窗: up to 5 years from the date of diagnosis
Description of the clinical, histological and radiological characteristics of various rare primary liver cancers
次要结局
- Recurrence-free survival (for non-metastatic patients)(up to 5 years from diagnosis)
- Progression-free survival (for metastatic patients)(up to 5 years from diagnosis)
- Overall survival(up to 5 years from diagnosis)